MLi-2

MLi-2 Struktur
1627091-47-7
CAS-Nr.
1627091-47-7
Englisch Name:
MLi-2
Synonyma:
MLi-2;MLi2,MLi-2,Inhibitor,Leucine-rich repeat kinase 2,inhibit,disease,orally,LRRK2,Parkinson’s,MLi 2;rel-(2S,6R)-2,6-Dimethyl-4-(6-(5-(1-methylcyclopropoxy)-1H-indazol-3-yl)pyrimidin-4-yl)morpholine;rel-3-[6-[(2R,6S)-2,6-Dimethyl-4-morpholinyl]-4-pyrimidyl]-5-[(1-methylcyclopropyl)oxy]-1H-indazole;1H-Indazole, 3-[6-[(2R,6S)-2,6-dimethyl-4-morpholinyl]-4-pyrimidinyl]-5-[(1-methylcyclopropyl)oxy]-, rel-
CBNumber:
CB83167643
Summenformel:
C21H25N5O2
Molgewicht:
379.46
MOL-Datei:
1627091-47-7.mol

MLi-2 Eigenschaften

Siedepunkt:
625.8±55.0 °C(Predicted)
Dichte
1.257±0.06 g/cm3(Predicted)
storage temp. 
Store at -20°C
Löslichkeit
DMSO: 15 mg/ml
Aggregatzustand
A crystalline solid
pka
11.24±0.40(Predicted)

Sicherheit

MLi-2 Chemische Eigenschaften,Einsatz,Produktion Methoden

Verwenden

MLi-2 is a leucine-rich repeat kinase 2 (LRRK2) inhibitor and may be used in the treatment and prevention of Parkinson’s disease as its a precursor to the illness.

MLi-2 Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


MLi-2 Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 51)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Henan Tianfu Chemical Co.,Ltd.
+86-0371-55170693 +86-19937530512
info@tianfuchem.com China 21691 55
Hangzhou FandaChem Co.,Ltd.
008657128800458; +8615858145714
fandachem@gmail.com China 9348 55
TargetMol Chemicals Inc.
+1-781-999-5354 +1-00000000000
marketing@targetmol.com United States 19892 58
Career Henan Chemica Co
+86-0371-86658258 15093356674;
laboratory@coreychem.com China 30255 58
NINGBOBENKANGJS PHARMTECHCO., LTD
+8615990591583 15990591583
CHINA 2029 58
HANGZHOU CLAP TECHNOLOGY CO.,LTD
86-571-88216897,88216896 13588875226
sales@hzclap.com CHINA 6313 58
Zhejiang J&C Biological Technology Co.,Limited
+1-2135480471 +1-2135480471
sales@sarms4muscle.com China 10523 58
InvivoChem
+1-708-310-1919 +1-13798911105
sales@invivochem.cn United States 6393 58
LEAP CHEM CO., LTD.
+86-852-30606658
market18@leapchem.com China 24738 58
Nantong HI-FUTURE Biology Co., Ltd.
+undefined18051384581
sales@chemhifuture.com China 3136 58

1627091-47-7()Verwandte Suche:


  • MLi-2
  • rel-3-[6-[(2R,6S)-2,6-Dimethyl-4-morpholinyl]-4-pyrimidyl]-5-[(1-methylcyclopropyl)oxy]-1H-indazole
  • 1H-Indazole, 3-[6-[(2R,6S)-2,6-dimethyl-4-morpholinyl]-4-pyrimidinyl]-5-[(1-methylcyclopropyl)oxy]-, rel-
  • rel-(2S,6R)-2,6-Dimethyl-4-(6-(5-(1-methylcyclopropoxy)-1H-indazol-3-yl)pyrimidin-4-yl)morpholine
  • MLi2,MLi-2,Inhibitor,Leucine-rich repeat kinase 2,inhibit,disease,orally,LRRK2,Parkinson’s,MLi 2
  • 1627091-47-7
Copyright 2019 © ChemicalBook. All rights reserved